Actively Recruiting
Effect of Hypnosis on Adherence to Continuous Positive Airway Pressure Therapy in Sleep-disordered Breathing: a Randomized Controlled Trial
Led by Solelhac Geoffroy · Updated on 2025-04-04
40
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Sleep-disordered breathing is common, affecting a large number of adults, with continuous positive airway pressure (CPAP) therapy being the standard treatment. However, many patients struggle to use CPAP consistently, which reduces its benefits. This trial evaluates whether medical hypnosis can help improve adherence to CPAP therapy by positively influencing patients' perceptions and experiences during the early treatment phase. Participants will be randomly assigned to either receive medical hypnosis sessions alongside their CPAP treatment or continue with standard care without hypnosis. The hypnosis involves guided sessions focused on creating a safe mental space and changing perceptions of CPAP, with tools for self-hypnosis at home. Follow-up visits occur about 4 to 6 weeks after treatment starts to collect CPAP usage data and complete questionnaires. During the study, participants will attend baseline and follow-up visits where data from CPAP machines and sleep-related questionnaires will be collected. Researchers will measure average hours of CPAP use, nights with more than 4 hours of use, sleepiness, sleep quality, insomnia symptoms, anxiety, and emotional status. The total participation period includes initial assessment and follow-up about 6 weeks after randomization to monitor adherence and patient-reported outcomes.
CONDITIONS
Brief Title
Effect of Hypnosis on Adherence to Continuous Positive Airway Pressure.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Prescribed long-term CPAP treatment for sleep-disordered breathing
- Use of CPAP less than 3 hours per night on average at second CPAP check-up (1 to 3 months after starting treatment)
- Ability to provide informed consent
You will not qualify if you...
- Refusal to experience hypnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 4 to 6 weeks
Participants in the hypnosis group receive two hypnosis sessions with recordings to practice self-hypnosis at home between visits. Those in the standard care group continue usual CPAP management without changes.
2 visits (in-person) for hypnosis group; routine care for standard care group
Duration - 4 to 6 weeks post-treatment
Participants complete follow-up visits to collect data from CPAP machines and questionnaires approximately 4 to 6 weeks after treatment sessions or 2 months after baseline for standard care.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
CHUVaudois
Lausanne, Canton of Vaud, Switzerland, 1011
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here